Abstract:Background: MicroRNA-106b (miR-106b) is thought to be an oncogenic microRNA that promotes tumor growth and metastasis. The potential predictive value of miR-106b was studied in colonic cancer patients. Methods: The expression of miR-106b was examined in 180 colonic cancer cases using in situ hybridization (ISH) technique and was evaluated semi-quantitatively by examining the staining index. The Correlation of miR-106b expression and clinic-pathological features was analyzed by Spearman Rank Correlation. Wilcoxon signed rank test was used for assessing the expression difference of miRNA-106b between colonic cancerous and para-cancerous ones, and their effects on patient survival were analyzed by a log-rank test and the Kaplan-Meier method. Results: MiR-106b was higher expressed in para-cancerous tissues, compared with colonic cancerous ones (P < 0.001). A positive correlation of miR-106b levels between colonic and para-cancerous tissues was also observed (CC = 0.523, P < 0.001). Furthermore, the expression of miR-106b was not significantly correlated with clinic-pathological parameters, including gender, age, histological grade, tumor size, pT stage, pN stage, pM stage and pTNM stage of the patients. Histological grade was positively correlated with pT stage (P = 0.011), pN stage (P = 0.036) and pTNM stage (P = 0.009). Patients expressing high levels of miR-106b both in colonic cancer tissues and para-cancerous ones have a relatively longer survival time but the difference is not statistically significant (P = 0.16). Conclusions: The expression difference of miR-106b levels between colonic tissues and para-cancerous tissues is statistically significant, but the miR-106b levels were not quite correlated with clinic-pathological characteristics and overall survival times of patients with colonic cancer. Lower levels of miR-106b may be connected with neoplastic effects due to interference with TGF-beta signaling, providing evidence that down-regulation of miR-106b might also play an important role in the progression of the disease. The study results are consistent with the literature and support the notion that miR-106b is an oncogenic microRNA.

Downregulation of Mir-193A-5p Correlates with Lymph Node Metastasis and Poor Prognosis in Colorectal Cancer

Expression and significance of miR-654-5p and miR-376b-3p in patients with colon cancer

Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer

Downregulation of Mir-138 Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.

In Situ Hybridization Analysis of the Expression of Mir-106B in Colonic Cancer.

Decreased expression of microRNA-192 correlates with tumor progression and poor prognosis in patients with colorectal cancer

Down-regulation of Mir-199B-5p is Correlated with Poor Prognosis for Breast Cancer Patients.

Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.

Downregulation of mir-23b in plasma is associated with poor prognosis in patients with colorectal cancer

Mir-204-5p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB22A.

Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior

Decreased Expression of Mir‑490‑3p in Colorectal Cancer Predicts Poor Prognosis and Promotes Cell Proliferation and Invasion by Targeting RAB14.

Up-regulation of microRNA-19b is associated with metastasis and predicts poor prognosis in patients with colorectal cancer

Up-regulation of Mir-592 Correlates with Tumor Progression and Poor Prognosis in Patients with Colorectal Cancer.

Upregulation of microRNA-196a and microRNA-196b cooperatively correlate with aggressive progression and unfavorable prognosis in patients with colorectal cancer

Clinical and Biological Significance of Mir-378a-3p and Mir-378a-5p in Colorectal Cancer

Expression Level and Potential Target Pathways of Mir-1-3p in Colorectal Carcinoma Based on 645ï¿½cases from 9 Microarray Datasets

Prognostic Significance of Serum Mir-193 B in Colorectal Cancer

miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.

Up-Regulation Of Mir-182-5p Predicts Poor Prognosis In Patients With Lung Cancer And Associates With Tumor Cell Growth And Migration

Overexpression of Mir-223 Correlates with Tumor Metastasis and Poor Prognosis in Patients with Colorectal Cancer